SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Nanny who wrote (160)11/4/1997 12:11:00 PM
From: Mack Earnhardt  Respond to of 4140
 
Nanny,

The reason I mention VISX and BEAM is that there have been mentions of Excimer being used to treat Hyperopia (thanks for correcting my terminology, btw). Of course, the exact treatment would have to be different, and LTK will most likely prove superior. I just think it would be better for Sunrise to be the first to gain approval to treat this condition.

-Mack



To: Nanny who wrote (160)11/4/1997 12:26:00 PM
From: Mack Earnhardt  Respond to of 4140
 
Nanny, or Anyone Who Knows,

I believe Sunrise still has a contract to supply laser components to Paradigm Medical for their new Cataract treatment device if and when it's approved. Would this be a significant revenue source for SNRS?

-Mack



To: Nanny who wrote (160)11/4/1997 3:58:00 PM
From: majormember  Read Replies (1) | Respond to of 4140
 
Nanny,

Just saw VISX has applied to treat hyperopia.
Does this change anything?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News